Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Study Details Chlamydia and Gonorrhea Co-Infection Rates in Hospital Patients

2 hours ago 1

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

A retrospective study conducted at the Second Affiliated Hospital of Xiamen Medical College between 2022 and 2025 has examined the clinical and laboratory characteristics of Chlamydia trachomatis infection and Neisseria gonorrhoeae co-infection. Evaluating 20,275 patients who underwent diagnostic testing, investigators compared positivity rates, demographic distributions, reported symptoms, and routine urinalysis parameters. Chlamydia trachomatis is the most common bacterial sexually transmitted infection worldwide, and co-infection with Neisseria gonorrhoeae occurs frequently among infected patients. However, localized data describing the presentation of these concurrent infections remain limited.

Among all tested individuals, the overall positivity rate for Chlamydia trachomatis reached 5.76 percent. Significant disparities emerged between sexes, with tested males demonstrating higher positivity than tested females at 12.87 percent versus 3.95 percent (P < 0.001). Rates of Neisseria gonorrhoeae co-infection among individuals already confirmed positive for chlamydia also diverged substantially. Male patients with chlamydia showed an accompanying gonococcal co-infection rate of 36.42 percent. In contrast, chlamydia-positive female patients exhibited a co-infection rate of only 8.46 percent, demonstrating a marked difference across tested patient groups (P < 0.001).

Age stratification revealed that adolescents and young adults exhibited the highest frequency of infection among groups with adequate sample sizes. Chlamydia positivity was highest among individuals aged 16 to 20 years at 14.62 percent. Within this age bracket, joint positivity for both pathogens among tested individuals was 4.56 percent. Furthermore, 31.21 percent of chlamydia-positive patients aged 16 to 20 carried a concurrent Neisseria gonorrhoeae infection. This youth co-infection rate split distinctly along sex lines, reaching 58.21 percent in young males compared with 11.11 percent in young females.

Multivariable analysis identified specific independent factors associated with Neisseria gonorrhoeae co-infection among chlamydia-positive patients. Male sex correlated with increased co-infection odds, yielding an adjusted odds ratio of 2.83 (P < 0.05). Younger age was also independently associated with co-infection, showing an adjusted odds ratio of 0.97 (P < 0.05). Additionally, the presence of urethral irritation presented an adjusted odds ratio of 3.29 (P < 0.05). These multivariable findings confirmed that demographic characteristics and localized symptoms were independently linked to concurrent gonococcal disease.

Clinical symptom manifestations displayed noticeable divergence between sexes and infection statuses. Male patients predominantly reported urethral irritation, which appeared far more frequently in dual co-infection than in solitary chlamydia infection, carrying an odds ratio of 6.19. Female patients presented with a broader spectrum of symptoms alongside a higher proportion of asymptomatic cases. Within the female cohort, vulvar discomfort proved more common among co-infected patients than among those infected solely with chlamydia, reflecting an odds ratio of 1.86 between the two diagnostic groups.

Laboratory urinalysis comparisons in male patients demonstrated substantial inflammatory differences between diagnostic categories. Co-infected males exhibited higher median urine white blood cell counts of 829.62 cells per microliter compared to 82.50 cells per microliter in males with solitary chlamydia. Median urine red blood cell counts were similarly elevated at 8.80 cells per microliter in co-infected males versus 4.21 cells per microliter in mono-infected counterparts. Furthermore, proteinuria positivity was significantly higher in dual infection at 29.7 percent compared to 11.1 percent in solitary infection, presenting an odds ratio of 3.39.

The study authors noted that these findings reflect observed retrospective associations from a single hospital setting and do not prove causal relationships. Although the observed increases in urine white blood cells, red blood cells, and proteinuria positivity correlate with dual infection in males, the researchers cautioned that the clinical utility of routine urinalysis requires validation in prospective investigations. The findings document key regional baseline patterns in transmission and presentation, highlighting the differing clinical expressions of chlamydia and gonococcal infections across patient populations.

Subject of Research: Clinical and laboratory characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection

Article Title: Clinical and laboratory characteristics of Chlamydia trachomatis infection and Neisseria gonorrhoeae co-infection: a retrospective study from a tertiary hospital in Xiamen, China, 2022–2025

Article References: Chen, Z.-B., He, W.-Q., Wang, H.-Y., Yan, X., Sun, L.-F., & He, Y. (2026). Clinical and laboratory characteristics of Chlamydia trachomatis infection and Neisseria gonorrhoeae co-infection: a retrospective study from a tertiary hospital in Xiamen, China, 2022–2025. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14896-x

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14896-x

Keywords: Chlamydia trachomatis, Neisseria gonorrhoeae, bacterial sexually transmitted infections, co-infection, retrospective cohort, Second Affiliated Hospital of Xiamen Medical College, urethral irritation, vulvar discomfort, urinalysis, proteinuria, urine white blood cells, urine red blood cells, asymptomatic infection, odds ratio, multivariable analysis, adolescent health

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway